Felicia Ruffin

2.4k total citations
71 papers, 1.4k citations indexed

About

Felicia Ruffin is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Felicia Ruffin has authored 71 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 36 papers in Epidemiology and 28 papers in Clinical Biochemistry. Recurrent topics in Felicia Ruffin's work include Antimicrobial Resistance in Staphylococcus (36 papers), Bacterial Identification and Susceptibility Testing (28 papers) and Infective Endocarditis Diagnosis and Management (23 papers). Felicia Ruffin is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (36 papers), Bacterial Identification and Susceptibility Testing (28 papers) and Infective Endocarditis Diagnosis and Management (23 papers). Felicia Ruffin collaborates with scholars based in United States, Greece and Netherlands. Felicia Ruffin's co-authors include Vance G. Fowler, Joshua T. Thaden, Stacey A. Maskarinec, Lawrence P. Park, Batu K. Sharma‐Kuinkel, David van Duin, Emily M. Eichenberger, Jonathan Hill-Rorie, Maria Souli and Thomas H. Rude and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Felicia Ruffin

61 papers receiving 1.3k citations

Peers

Felicia Ruffin

EPIDE

PHEOH

Sara Droz Switzerland

Achim J. Kaasch Germany

Petra Apfalter Austria

Julie Pearson Australia

Rosemary C. She United States

Celestino Bonura Italy

Abhay Dhand United States

Elizabeth Palavecino United States

Raymond T. P. Lin Singapore

Uga Dumpis Latvia

Sara Droz Switzerland

Felicia Ruffin

455 ×0.7

472 ×1.1

EPIDE

193 ×0.4

239 ×0.9

PHEOH

396 ×1.5

Citations per year, relative to Felicia Ruffin Felicia Ruffin (= 1×) peers Sara Droz

Countries citing papers authored by Felicia Ruffin

Since Specialization

Citations

This map shows the geographic impact of Felicia Ruffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felicia Ruffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felicia Ruffin more than expected).

Fields of papers citing papers by Felicia Ruffin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felicia Ruffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felicia Ruffin. The network helps show where Felicia Ruffin may publish in the future.

Co-authorship network of co-authors of Felicia Ruffin

This figure shows the co-authorship network connecting the top 25 collaborators of Felicia Ruffin. A scholar is included among the top collaborators of Felicia Ruffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felicia Ruffin. Felicia Ruffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thaden, Joshua T., P. Cox, Sanjay Khandelwal, et al.. (2025). Escherichia coli Type III Secretion System 2 Is Associated With Patient Mortality in Bloodstream Infections. The Journal of Infectious Diseases. 232(5). 1097–1107.

Minter, Daniel J., Karen D. Barton, Lesley A. Skalla, et al.. (2025). A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Complicated Urinary Tract Infections. Clinical Infectious Diseases. 81(Supplement_1). S16–S23.

Norman, Katherine, Emily Lydon, Karen D. Barton, et al.. (2025). A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Acute Bacterial Skin and Skin Structure Infections. Clinical Infectious Diseases. 81(Supplement_1). S24–S31.

Zheng, Ying, Maura Rossetti, Felicia Ruffin, et al.. (2025). Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia. BMC Infectious Diseases. 25(1). 231–231.

Krah, Nathan M., Katherine Norman, Karen D. Barton, et al.. (2025). A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia. Clinical Infectious Diseases. 81(Supplement_1). S32–S39.

Galloway-Peña, Jessica, David van Duin, Leila Ledbetter, et al.. (2024). Participant Diversity in United States Randomized Controlled Trials of Antibacterials for Staphylococcus aureus Infections, 2000–2021. Clinical Infectious Diseases. 79(1). 141–147. 2 indexed citations

Parsons, Joshua B., Blake Hanson, Felicia Ruffin, et al.. (2024). In-patient evolution of a high-persister Escherichia coli strain with reduced in vivo antibiotic susceptibility. Proceedings of the National Academy of Sciences. 121(3). e2314514121–e2314514121. 15 indexed citations

Ruffin, Felicia, Blake Hanson, César A. Arias, et al.. (2024). Persistent Gram-negative Bloodstream Infection Increases the Risk of Recurrent Bloodstream Infection With the Same Species. Clinical Infectious Diseases. 78(6). 1458–1461. 2 indexed citations

Pickering, Harry, Richard Ahn, Maura Rossetti, et al.. (2024). Integrated transcriptomic analysis reveals immune signatures distinguishing persistent versus resolving outcomes in MRSA bacteremia. Frontiers in Immunology. 15. 1373553–1373553. 2 indexed citations

10.

Dagher, Michael, et al.. (2023). Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients With Staphylococcus aureus Bacteremia. Clinical Infectious Diseases. 77(9). 1226–1233. 12 indexed citations

11.

Tao, Yazhong, Derek M. Dykxhoorn, Felicia Ruffin, et al.. (2023). 307. Exploring HLA genotypes as contributing risk factors in Staphylococcus aureus bacteremia. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

12.

Buis, David T.P., Kim Sigaloff, Felicia Ruffin, et al.. (2023). Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care. Clinical Infectious Diseases. 77(8). 1092–1101. 20 indexed citations

13.

Xavier, João B., Jonathan M. Monk, Saugat Poudel, et al.. (2022). Mathematical models to study the biology of pathogens and the infectious diseases they cause. iScience. 25(4). 104079–104079. 11 indexed citations

14.

Maskarinec, Stacey A., Felicia Ruffin, Nicholas Turner, et al.. (2020). Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia. Clinical Microbiology and Infection. 26(7). 904–910. 46 indexed citations

15.

Eichenberger, Emily M., Felicia Ruffin, Michael Dagher, et al.. (2020). Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study. American Journal of Transplantation. 21(6). 2113–2122. 8 indexed citations

16.

Sutton, Granger, Felicia Ruffin, Lawrence P. Park, et al.. (2020). Newly Named Klebsiella aerogenes (formerly Enterobacter aerogenes) Is Associated with Poor Clinical Outcomes Relative to Other Enterobacter Species in Patients with Bloodstream Infection. Journal of Clinical Microbiology. 58(9). 37 indexed citations

17.

Eichenberger, Emily M., Michael Dagher, Felicia Ruffin, et al.. (2020). Complement levels in patients with bloodstream infection due to Staphylococcus aureus or Gram-negative bacteria. European Journal of Clinical Microbiology & Infectious Diseases. 39(11). 2121–2131. 8 indexed citations

18.

Nelson, Charlotte, Kimberly Pelak, Mihai V. Podgoreanu, et al.. (2014). A genome-wide association study of variants associated with acquisition of Staphylococcus aureus bacteremia in a healthcare setting. BMC Infectious Diseases. 14(1). 83–83. 29 indexed citations

19.

David, Michael, Robert S. Daum, Arnold S. Bayer, et al.. (2014). Staphylococcus aureus Bacteremia at 5 US Academic Medical Centers, 2008-2011: Significant Geographic Variation in Community-Onset Infections. Clinical Infectious Diseases. 59(6). 798–807. 76 indexed citations

20.

Tong, Steven Y. C., Yurong Zhang, Supaporn Lamlertthon, et al.. (2012). Panton-Valentine Leukocidin Is Not the Primary Determinant of Outcome for Staphylococcus aureus Skin Infections: Evaluation from the CANVAS Studies. PLoS ONE. 7(5). e37212–e37212. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact